Teodorikez J.
- Country
- Spain
- Department
- Allergy
Research Overview
- Efficacy and Safety of Subcutaneous Dermatophagoides Allergoid Immunotherapy in Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma
- Evaluation of the Efficacy and Safety of Mannan-Conjugated Allergoids in Moderate-to-Severe Allergic Rhinitis/Rhinoconjunctivitis with or without Controlled Asthma
Data & Insights
Has run more than one trial at 2 of 30 partner sites.
Specializations
Allergic Respiratory Disorders
This investigator specializes in the treatment of allergic respiratory conditions, with particular emphasis on the management of rhinitis and rhinoconjunctivitis. Their research encompasses both intermittent and persistent forms of these conditions.
- Moderate to severe allergic rhinitis
- Allergic rhinoconjunctivitis
- Controlled allergic asthma
Their clinical focus includes comprehensive treatment approaches for patients with combined respiratory allergies.
Allergen-Specific Immunotherapy
The investigator has developed expertise in allergen-specific immunotherapy, particularly focusing on treatments for house dust mite allergies. Their work involves innovative approaches to immunological interventions.
- Polymerized allergen extracts
- Mannan-conjugated allergoids
- Subcutaneous immunotherapy
Their research explores advanced immunotherapeutic solutions for allergic respiratory conditions.
Clinical Therapeutics
The investigator's therapeutic approach focuses on aetiological treatment methods for respiratory allergies. Their expertise extends to managing patients with various severity levels of allergic conditions.
- Combined respiratory allergy management
- Personalized treatment approaches
- Long-term disease control
Their work emphasizes comprehensive treatment strategies for both isolated and combined allergic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.